Jaguar in distribution pact for Neonorm in Japan

Jaguar Animal Health (NASDAQ:JAGX) has signed an exclusive distribution agreement with JP Equine Services for distribution of Jaguar’s lead non-prescription products, Neonorm Foal and Neonorm Calf, in Japan.

Neonorm Foal is a natural, clinically tested, non-drug product designed for use as an anti-diarrheal in newborn horses. Neonorm Calf has been formulated and clinically tested to help proactively retain fluid in dairy calves and reduce the severity of diarrhea—aiding calves in avoiding debilitating, dangerous levels of dehydration associated with scours.

Headquartered in Jamaica, NY and established in 2001, JP Equine Services began as a shipping company handling transport of thoroughbred racehorses to Japan, Korea, Saudi Arabia and Italy. The company later expanded into distribution of equine products to breeding farms and veterinary practices throughout the world.

Henry Schein continues to serve as Jaguar’s exclusive distributor of Neonorm Foal in the U.S. equine market.